Pharmacotherapeutic strategies for epithelioid sarcoma: are we any closer to a non-surgical cure?

ES is a soft tissue sarcoma with a heterogeneous pathological, clinical and molecular presentation. In the current era of precision medicine, more trials with targeted therapies and a combination of chemotherapy or immunotherapy with targeted therapies are required to establish optimal treatment for ES.